In the challenging field of spinal surgery, improving clinical outcomes and boosting satisfaction for both patients and surgical teams remain the core criteria for successful technological innovation.
On June 10, 2024, Professor Jean Charles Le Huec, a globally acclaimed spinal deformity specialist and former President of EUROSPINE, performed the world’s first implantation of the Zeus Spinal System in Bordeaux, France. On November 21, 2024, Dr. Chris O'Boynick, a renowned specialist in spinal deformity correction, successfully performed the first-ever U.S. implantation of the Zeus Spinal System in Missouri. To date, leading specialists across China, the U.S., and Europe have adopted the Zeus Spinal System for the treatment of a wide range of spinal disorders, including adolescent idiopathic scoliosis (AIS), severe lumbar spondylolisthesis, and degenerative change. The system has delivered outstanding postoperative outcomes and earned highly positive clinical feedback worldwide.
Developed based on Sanyou’s decade-long clinical experience accumulated from hundreds of thousands of posterior thoracolumbar fixation procedures, the Zeus Spinal System was created by a core R&D team led by Dr. Ma Yuli, Director of the R&D Department, under the guidance of Dr. Liu Mingyan, Chairman and Chief Scientist of Sanyou. Team members Liu Ruifeng, Zhang Zhenfeng, and Fang Shangqing devoted four years to addressing unmet clinical challenges through original design concepts and independent technological breakthroughs.
The R&D team overcame numerous technical obstacles throughout the four-year development journey.
I. Meeting the Need for a Comprehensive Implant Portfolio
Spinal pathologies range widely from deformity, degeneration and spondylolisthesis to trauma, spinal tumors and infections. Given varying patient factors such as age, height, and weight, surgeons create personalized surgical protocols based on each patient’s clinical status. To achieve optimal therapeutic outcomes, surgeons need a broad range of implant options. Driven by real clinical needs, the Zeus R&D team created over 20 types of screws and accessories to address complex cases, including deformity, revision, and pediatric spinal conditions. This comprehensive screw portfolio allows surgeons to select the best-matching implant for each patient for better surgical outcomes.

II. Balancing the Demands of Flexible and Rigid Tubular Retractors
Different minimally invasive spine surgery approaches require different instruments—some need flexible retractors, others rigid tubular retractors. To minimize incisions, the R&D team repeatedly refined instrument dimensions. They evaluated and validated every 0.1 mm increment for components that directly impact incision length. Zeus features a world-first hybrid flexible-rigid minimally invasive instrument set, reducing incisions to just 1.5 cm, which significantly minimizes tissue damage and reduces postoperative infection risk compared to 3–5 cm in conventional open surgery. The hybrid design adapts flexibly to diverse surgical scenarios: rigid tubular retractors facilitate fracture reduction, while flexible retractors enable long-segment treatment with precise control. Designed for a variety of complex spinal conditions such as idiopathic scoliosis and thoracolumbar fractures, this system provides surgeons with more surgical approaches. Its exclusive flexible-rigid switching mechanism allows surgeons to adjust instruments during surgery as needed, improving overall efficiency.

III. Reducing Surgery Time
Every minute saved during surgery frees up surgeons’ time, reduces tissue damage, and lowers risks. To balance insertion speed with pullout strength, the R&D team used Design of Experiments (DOE) methodology to quantify the impact of each variable and determine optimal design parameters. Zeus introduces a first-in-China Quattro thread design. Its unique self-tapping tip eliminates pre-tapping in most cases, increasing screw insertion speed by over 50%. The quattro thread also nearly doubles cortical bone purchase compared to traditional double-thread designs, significantly improving fixation in osteoporotic bone, making surgery safer, faster, and less demanding.

IV. Pursuing Precision in Spinal Deformity Correction
Scoliosis is a three-dimensional spinal deformity, which is primarily characterized by coronal lateral curvature that creates a C-shaped or S-shaped spinal profile, accompanied by vertebral axial rotation. Surgeons work in a narrow field surrounded by critical neural, vascular, and muscular structures, requiring precise manipulation to avoid tissue damage. After analyzing the limitations of conventional instruments and incorporating surgeons’ intraoperative needs, the R&D team developed an innovative clip with a lateral unidirectional anchoring design. Providing simple, stable, and reliable fixation, it enables surgeons to perform next-generation co-planar reduction more quickly. Conventional correction typically requires two rods, while Zeus achieves complete three-dimensional correction with a single rod, cutting surgery time by 40%. In scoliosis correction procedures, the single-rod three-dimensional correction technology of Zeus delivers superior correction outcomes compared to traditional dual-rod constructs. It streamlines surgical procedures, reduces surgical risks, and achieves a very low rate of postoperative complications.

V. Simplifying Intraoperative Instrumentation
A large, complex instrument set prolongs surgeons’ familiarization process and extends surgery time. Through innovative design, the R&D team consolidated existing instruments into a modular system, reducing the variety and number of instruments while cutting production and operational costs. Most Zeus screws and accessories can be driven with a single universal driver. This design improves efficiency, reduces sterilization and transportation costs, and shortens surgeons’ familiarization process.

Throughout the R&D process of Zeus, the R&D team consistently upheld Sanyou’s core mission of “Advancing Therapeutic Innovation, Empowering Surgeons to Elevate Patients’ Quality of Life, and Translating Surgeons’ Clinical Insights into Tangible Benefits for Patients.” Supported by Sanyou’s complete in-house product R&D framework and Tytus Lab’s advanced testing capabilities, the R&D team ensured that Zeus delivers industry-leading performance, proven effectiveness, and reliable clinical stability.
Zeus represents multiple breakthrough innovations—from implant design to intraoperative instrumentation. Its comprehensive implant portfolio, flexible combination of reduction techniques, second-generation co-planar correction technology, and world-first hybrid flexible-rigid minimally invasive (MIS) concept together set a new standard in thoracolumbar posterior fixation, capable of addressing all documented thoracolumbar deformity correction and minimally invasive internal fixation techniques. A total of 8 national invention patents have been filed for Zeus, and its instrument set received the Red Dot Design Award 2025.